Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist
Contact+90 (538) 677 60 18

The 7 Most Misunderstood Medical Terms in Cancer

The 7 Most Misunderstood Medical Terms in Cancer
In this article
Progression, stable disease, remission… The same word can be a technical measure for a physician and a source of anxiety for a patient. This guide explains the most commonly confused terms simply and accurately.

Why Is There So Much Confusion?

Many terms used in oncology are based on imaging measures (CT/PET) and standardized assessment criteria. From a patient's perspective, however, these words often get reduced to good news versus bad news. Yet in clinical practice, some expressions can have a neutral or even positive meaning.

The Golden Rule: It is entirely normal to ask, “What does this mean for me?” when you hear a term. The same word can be interpreted differently depending on the cancer type and stage, the treatment goal, and the measurement method.

A Quick Map to Help You Read

WHAT THE TERMS MEAN IN REAL LIFE
What the doctor means:
  • Is there a measurable change?
  • Is the disease under control?
  • Should the current treatment plan continue?
  • Is another assessment or test needed?
The patient's common mistaken conclusion:
  • “It is over / completely gone.”
  • “Everything is getting worse.”
  • “The treatment was wasted.”
  • “They have given up.”

The 7 Most Commonly Confused Terms

For each term, the cards below provide: the patient's common interpretation, the medical meaning and the best question to ask when you hear the term .

1) Progression

The patient's common interpretation: “Everything is getting worse.”

Medical meaning: The disease has advanced compared with the previous assessment according to standard criteria, such as growth of some lesions or the appearance of a new site.

Often misunderstood
Ask when you hear this term: “Is this progression rapid? Is it confined to one area? Is our treatment goal to shrink the disease or control it?”

2) Stable Disease

The patient's common interpretation: “The treatment is not working.”

Medical meaning: The disease has not shrunk substantially, but it has not progressed either; in other words, it is under control.

Often good news
Ask when you hear this term: “Does remaining stable fit our goal? What will the follow-up interval be?”

3) Partial Response

The patient's common interpretation: “I have not fully recovered.”

Medical meaning: The tumor burden has decreased substantially, but it has not disappeared completely.

A positive response
Ask when you hear this term: “What is the degree of response and its clinical significance? Do we continue the same treatment or move to maintenance?”

4) Complete Response

The patient's common interpretation: “The cancer is completely gone.”

Medical meaning: Measurable disease cannot be detected through imaging or clinical findings.

Confused with a cure
Ask when you hear this term: “What is our follow-up plan to sustain this complete response? Is there an additional or preventive strategy to reduce the risk of recurrence?”

5) Remission

The patient's common interpretation: “There is none left at all.”

Medical meaning: Signs of the disease have substantially decreased or become undetectable. Remission can be complete or partial.

Not equivalent to being cured
Ask when you hear this term: “Is this remission complete or partial? How often will follow-up tests be performed?”

6) Recurrence

The patient's common interpretation: “The treatment was wasted.”

Medical meaning: The disease reappears after being under control for a period of time.

A new plan is made
Ask when you hear this term: “Is the recurrence local or widespread? What are the options for targeted therapy, immunotherapy, surgery, or radiotherapy?”

7) A Treatment Break

The patient's common interpretation: “They have given up.”

Medical meaning: A planned or unplanned pause to manage side effects, protect organs, allow recovery, or strategically reassess the situation.

It does not mean it is over
Ask when you hear this term: “How long will the break last? Is supportive treatment available during this time? What should I report immediately?”

What Most Often Leads to Misinterpreting These Terms?

Two people looking at the same report may think different things. Common pitfalls that increase misinterpretation include:

  • Differences between imaging methods: CT and PET do not answer the same question. CT mainly shows size; PET provides clues about metabolic activity.
  • Measurement error: Millimeter-scale differences can sometimes arise from the equipment or scanning technique and may sometimes be clinically insignificant.
  • The possibility of pseudoprogression during immunotherapy: Although rare, immune cells entering the tumor can make it appear temporarily larger on imaging. Doctors evaluate this using separate assessment criteria.
  • A change in treatment goals: For some cancers, the goal is long-term control rather than complete disappearance. Stable disease can therefore be very valuable.
A Mini Checklist: Questions for Your Appointment
  • “Is this term considered good or bad in my disease?”
  • “Is the goal of treatment to shrink the disease or to control it?”
  • “What criteria were used for this assessment? CT/PET, measurement criteria, and so on?”
  • “What exactly is our next step?”
DROZDOGAN Academy Note

A misunderstanding can even affect treatment.

This is something we frequently see in oncology practice: patients assume stable is bad and lose hope, interpret complete response as no risk remaining and become less diligent with follow-up, or understand a treatment break as giving up.

The right question, however, is: “What does this term mean for my cancer and my treatment goal?” Simply asking this at an appointment can dramatically improve communication.

Note: This article provides general information. Assessment methods and clinical meaning can differ for each patient. Always interpret your own report together with your treating oncology team.

Scientific References
  • Eisenhauer EA, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). European Journal of Cancer. 2009.
  • Seymour L, et al. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. The Lancet Oncology. 2017.
  • National Cancer Institute (NCI). Dictionary of Cancer Terms: Remission, Recurrence, Progression, Response. (Patient dictionary/terminology guide).
  • ASCO (American Society of Clinical Oncology) Patient Information. “Understanding scans and treatment response”. (Patient information materials).
  • ESMO (European Society for Medical Oncology) Patient Guides. “How to understand treatment outcomes and follow-up”.
  • Street RL Jr, et al. Patient-centered communication in cancer care: promoting healing and reducing suffering. (Literature on communication in cancer care).
DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

The 7 Most Misunderstood Medical Terms in Cancer

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy